title: Recombinant human erythropoietin (r-HuEPO) increases total bilirubin production in premature infants.
authors.affiliation: Department of Pediatrics, Stanford University School of Medicine, California, USA.
authors.forename: L M
authors.initials: LM
authors.lastname: Baxter
authors.forename: H J
authors.initials: HJ
authors.lastname: Vreman
authors.forename: B
authors.initials: B
authors.lastname: Ball
authors.forename: D K
authors.initials: DK
authors.lastname: Stevenson
mesh_terms: D000740:Anemia / Q000378:metabolism / Q000628:therapy*; D001663:Bilirubin / Q000096:biosynthesis*; D001803:Blood Transfusion; D002263:Carboxyhemoglobin / Q000378:metabolism; D004311:Double-Blind Method; D004921:Erythropoietin / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000378:metabolism / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D002263:Carboxyhemoglobin; D001663:Bilirubin